- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 5 - The Use of Tools and Electronic Health Records in Pathway Adherence
In this segment, panelists discussed the various tools that are used to measure pathway adherence.
In this segment, panelists discussed the various tools that are used to measure pathway adherence.
Dr Nabhan said that short of monitoring patients' adherence to the proper pathways via electronic health records (EHR), there are not many tools that come to mind for driving adherence. He said there should always be the expectation that some patients will not be adherent.
Dr Tischler said due to variability, there may be up to 25% of patients who “fall out” of adherence. However, providers have a responsibility to determine what the cause of non-adherence is. Web portal monitoring could be 1 way to make this easier and more streamlined.
In fact, Dr Malin said that WellPoint uses a Web portal to monitor adherence. However, the tools and goals of pathways adherence can be different. Some pathways have a “single-best approach” that focuses on population health management, where other pathways can have 3-4 treatment options that might be applicable.
“I think when you’re looking at adherence rates across different pathway programs, you can’t necessarily assume that you should see the same benchmark for different programs because it may vary with how the program is designed,” said Dr Malin.
Dr Yu said he has not seen successful integration of pathways with the EHR commonly used by oncologists. The current system can cause extra work, and there is lack of efficient pathway mapping. Vendors also currently lack incentive to improve EHR systems.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Reducing Low-Value Care Is Hard, but What About Just Not Paying for It?
March 14th 2024After years of efforts to reduce low-value care, panelists at the 2024 Value-Based Insurance Design Summit proposed a new strategy: drawing a line in the sand that payers will not be on the hook for these services.
Read More
